These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6013 related articles for article (PubMed ID: 2998613)

  • 21. Modulation of terminal differentiation and responses to tumor promoters by retinoids in mouse epidermal cell cultures.
    Yuspa SH; Lichti U; Ben T; Hennings H
    Ann N Y Acad Sci; 1981 Feb; 359():260-73. PubMed ID: 6942677
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and epidermal ornithine decarboxylase activity in mouse skin by palmitoylcarnitine.
    Nakadate T; Yamamoto S; Aizu E; Kato R
    Cancer Res; 1986 Apr; 46(4 Pt 1):1589-93. PubMed ID: 3081251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of biological actions of 12-O-tetradecanoylphorbol-13-acetate by inhibitors of protein kinase C.
    Tanaka K; Ono T; Umeda M
    Jpn J Cancer Res; 1986 Nov; 77(11):1107-13. PubMed ID: 3025144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione: its role in inhibition of tumor promotion.
    Gopalakrishna R; Chen ZH; Gundimeda U
    Arch Biochem Biophys; 1997 Dec; 348(1):37-48. PubMed ID: 9390172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitro.
    Seifert M; Rech M; Meineke V; Tilgen W; Reichrath J
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):375-9. PubMed ID: 15225804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
    Verma AK
    Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paradoxical effect of anthralin on 12-O-tetradecanoylphorbol-13-acetate-induced mouse epidermal ornithine decarboxylase activity, proliferation, and tumor promotion.
    De Young LM; Helmes CT; Chao WR; Young JM; Miller V
    Cancer Res; 1981 Jan; 41(1):204-8. PubMed ID: 7448761
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific role for protein kinase C beta in cell differentiation.
    Gamard CJ; Blobe GC; Hannun YA; Obeid LM
    Cell Growth Differ; 1994 Apr; 5(4):405-9. PubMed ID: 8043514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase activation and the immunosuppressant cyclosporine.
    Fidelus RK; Laughter AH
    Transplantation; 1986 Feb; 41(2):187-92. PubMed ID: 3003975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of differentiation of HL-60 cells by different agents and the phospholipid-sensitive Ca++ dependent protein phosphorylation system.
    Zylber-Katz E; Glazer RI
    Rev Clin Basic Pharm; 1985; 5 Suppl():49S-56S. PubMed ID: 3870422
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1 alpha,25-Dihydroxyvitamin D3 induces anchorage-independent growth and c-Ki-ras expression of BALB/3T3 and NIH/3T3 cells.
    Huh N; Satoh M; Nose K; Abe E; Suda T; Rajewsky MF; Kuroki T
    Jpn J Cancer Res; 1987 Feb; 78(2):99-102. PubMed ID: 3030988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A
    Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of transformation and promotion of mouse epidermal cells.
    Yuspa SH
    Carcinog Compr Surv; 1985; 9():271-82. PubMed ID: 4053078
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro modulation of oncogenesis and differentiation by retinoids and tumor promoters.
    Borek C; Miller RC; Geard CR; Guernsey DL; Smith JE
    Carcinog Compr Surv; 1982; 7():277-84. PubMed ID: 6461410
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunomodulating properties of 1,25-dihydroxyvitamin D3.
    Manolagas SC; Hustmyer FG; Yu XP
    Kidney Int Suppl; 1990 Sep; 29():S9-16. PubMed ID: 2170738
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible functions of 1 alpha,25-dihydroxyvitamin D3, an active form of vitamin D3, in the differentiation and development of skin.
    Kuroki T
    J Invest Dermatol; 1985 Jun; 84(6):459-60. PubMed ID: 2987363
    [No Abstract]   [Full Text] [Related]  

  • 39. Pathological and biochemical aspects of tumour promotion.
    Hicks RM
    Carcinogenesis; 1983 Oct; 4(10):1209-14. PubMed ID: 6616751
    [No Abstract]   [Full Text] [Related]  

  • 40. 1 alpha,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells.
    Miyaura C; Abe E; Kuribayashi T; Tanaka H; Konno K; Nishii Y; Suda T
    Biochem Biophys Res Commun; 1981 Oct; 102(3):937-43. PubMed ID: 6946774
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 301.